Skip to main content
. 2022 Nov 29;10(12):3069. doi: 10.3390/biomedicines10123069

Figure 1.

Figure 1

Impact of COVID-19 pandemic on HM patients. HM patients show an impaired immune response and suffered from delays of anticancer therapies during the pandemic. These conditions made them more vulnerable to infection and to develop psychological distress. Figure created with BioRender.